Popular Trials
Vasopressin Analog
PB for Nephrogenic Diabetes Insipidus
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial is testing a drug called PB to see if it can help people who urinate frequently due to certain kidney conditions or treatments. It aims to help the kidneys manage water better, so patients don't have to go to the bathroom as often.
Popular Filters
Trials for PKD Patients
Behavioural Intervention
Dietary Intervention for Polycystic Kidney Disease
Recruiting1 award3 criteria
Loma Linda, California
This trial aims to see how a specific diet affects certain markers in the body and the progression of kidney cysts in individuals with a specific kidney disease. The researchers will compare the results of those following the
Procedure
Amnioinfusion for Fetal Kidney Anomalies
Recruiting1 award7 criteria
Dallas, Texas
This trial aims to see if giving regular amnioinfusions to fetuses with severe kidney problems can improve their chances of survival. The study will also investigate if this procedure helps the fetus survive until dial
Nutritional Therapy
Ketogenic Diet for Kidney Disease
Recruiting1 award2 criteria
Columbus, Ohio
This trial will study how a ketogenic diet affects kidney function in patients with a certain type of kidney disease. They will recruit 20 patients with high-risk kidney disease and assess their kidney function using imaging scans
Antisense Oligonucleotide
RGLS8429 for Polycystic Kidney Disease
Recruiting0 awardsPhase 1
Nampa, Idaho
This trial tests a new drug called RGLS8429 to see if it is safe and effective for people with a specific kidney disease called ADPKD. The drug is given through an injection under the skin. Researchers will check if it helps improve kidney health and function.
Empagliflozin for Polycystic Kidney Disease
Recruiting0 awardsPhase 2
Aurora, Colorado
This trial tests empagliflozin, a drug that helps remove excess sugar through urine, in patients with ADPKD who suffer from kidney cysts and eventual kidney failure. The drug may help reduce kidney damage and improve heart health by blocking a protein that reabsorbs sugar. Empagliflozin has been shown to slow the progression of diabetic kidney disease.
Diuretic
Hydrochlorothiazide for Polycystic Kidney Disease
Recruiting1 awardPhase 3
Boston, Massachusetts
This trial is testing if adding hydrochlorothiazide, a common blood pressure medication, to the existing kidney disease treatment Tolvaptan can improve its effectiveness and reduce side effects. The study targets adults with a specific type of kidney disease who are already on Tolvaptan. Tolvaptan helps slow kidney damage but can cause excessive urination, and hydrochlorothiazide might help manage this issue. Tolvaptan is the only approved drug for this type of kidney disease and has been shown to slow its progression.
Trials With No Placebo
Behavioural Intervention
Dietary Intervention for Polycystic Kidney Disease
Recruiting1 award3 criteria
Loma Linda, California
This trial aims to see how a specific diet affects certain markers in the body and the progression of kidney cysts in individuals with a specific kidney disease. The researchers will compare the results of those following the
Procedure
Amnioinfusion for Fetal Kidney Anomalies
Recruiting1 award7 criteria
Dallas, Texas
This trial aims to see if giving regular amnioinfusions to fetuses with severe kidney problems can improve their chances of survival. The study will also investigate if this procedure helps the fetus survive until dial
Nutritional Therapy
Ketogenic Diet for Kidney Disease
Recruiting1 award2 criteria
Columbus, Ohio
This trial will study how a ketogenic diet affects kidney function in patients with a certain type of kidney disease. They will recruit 20 patients with high-risk kidney disease and assess their kidney function using imaging scans
Vasopressin V2 receptor antagonist
Tolvaptan for Polycystic Kidney Disease
Recruiting2 awardsPhase 3
Washington, District of Columbia
This trial is testing tolvaptan, a medication that slows kidney damage, in children with a severe kidney disease called ARPKD. Tolvaptan works by blocking a hormone that causes the kidneys to hold too much water, helping to reduce cysts and protect kidney function. The study will monitor children taking tolvaptan for a period of time. Tolvaptan has been shown to slow the progression of renal disease in adults with ADPKD, but its use in children is still being studied.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.